- Renowned entrepreneur, innovator, physician-scientist and advisor
- Extensive experience building businesses and investing in healthcare across Africa
- Began his career as a physician-scientist at Skirball Institute of Bio-molecular Medicine in New York, where he cloned two genes involved in organ patterning and regeneration
Dr Felix Olale is a Partner at LeapFrog and the firm’s Global Co-Leader for Health Investments. He is also an entrepreneur and physician-scientist, renowned for his work building businesses and investing in healthcare in emerging markets.
Prior to LeapFrog, Dr Olale was Chairman of the Excelsior Group, a US-Africa based advisor and investor in health and technology companies. Dr Olale was also Senior Advisor to the International Finance Corporation (IFC) for their Health in Africa Initiative. In addition, Dr Olale was co-founder of the Institute for Healthcare Management at Strathmore Business School, and a founding member of Safaricom’s Health Advisory Board.
Dr Olale began his career as a physician-scientist at Skirball Institute of Bio-molecular Medicine in New York, where he cloned two genes involved in organ asymmetry and regeneration. He then worked in venture capital with New York University’s Office of Industrial Liaison and Technology Transfer. Later, he was an Associate Partner at McKinsey & Company in New York, where he was a leader in the Pharmaceutical, Medical Products and Global Health practices.
Dr Olale holds a Bachelor of Arts (Hons.) in Molecular Biology from the University of Pennsylvania, where he was a University Scholar. He received his Medical Degree and Doctorate from New York University’s School of Medicine. Dr Olale serves as a Board Trustee and Chairman of the Governance Committee for PATH, the leading global health innovator and is a Member of EMPEA’s Africa Council.